- Residency - UT Health Science Center at San Antonio (1988-1990), Podiatric Medicine & Surgery
- Fellowship - UT Health Science Center at San Antonio (1992-1993), Podiatric Medicine & Surgery
- Medical School - UT Health Science Center at Houston (1991-1993)
- Medical School - Rosalind Franklin University of Medicine & Science (1984-1988)
Larry Lavery, D.P.M.
- Plastic Surgery
Lawrence A. Lavery, D.P.M., M.P.H., is a Professor in the Department of Plastic Surgery at UT Southwestern Medical Center. He is also the medical director of the amputation prevention program at Parkland Memorial Hospital. Dr. Lavery’s clinic and research interests involve diabetic foot complications, infections, and wound healing.
Dr. Lavery completed his undergraduate studies at Indiana University and then earned his medical degree at the Rosalind Franklin University of Medicine and Science, Dr. William Scholl College of Podiatric Medicine in Chicago. He completed a residency in podiatric medicine and surgery at the University of Texas Health Science Center in San Antonio, where he also earned a Master in Public Health.
He is board certified by the American Board of Podiatric Surgery and a Fellow of the American College of Foot and Ankle Surgeons and the Royal College of Surgeons (Glasgow).
Prior to joining UT Southwestern in 2010, Dr. Lavery was a professor in the Department of Surgery at the Texas A&M Health Science Center College of Medicine, Scott and White Medical Center in Temple, Texas; the University of Texas Health Science Center in San Antonio; and Loyola University Medical Center in Maywood, Illinois. He has also served as a staff podiatrist at VA hospitals in San Antonio and Maywood, Illinois.
Dr. Lavery’s research group has published over 320 peer reviewed scientific paper and textbook chapters. They have received research funding from the National Institutes of Health, Agency for Health Care Policy and Research, American Diabetes Association, Veterans Administration, Qatar National Research Foundation, American College of Foot and Ankle Surgeons, American Podiatric Medical Association, and private industry.
Meet Larry Lavery
Wound Care Specialist
A board-certified podiatrist, Lawrence Lavery, D.P.M., M.P.H., is an internationally recognized expert in diabetic foot complications, including diabetic foot ulcers, soft tissue and bone infections, Charcot arthropathy, and prevention strategies. As a leading member of the team that established UT Southwestern’s Wound Care Clinic, he’s been at the forefront of expanding options for patients in North Texas.
Dr. Lavery currently is a member of the International Working Group on the Diabetic Foot, including both the diabetic foot infection and diabetic foot prevention study groups. He is past chair of the American Diabetes Association Foot Care Counsel and the American Public Health Association’s Foot Section.
"We apply comprehensive solutions focused on helping patients recover. For some patients, this means salvaging a limb using advanced techniques based on the newest research available in wound care.”
By combining groundbreaking research with scientific treatment options, he’s able to offer novel, evidenced-based treatments. His expertise includes the full range of wound care options – including stem cell-based wound therapy, bioengineered tissue, electrical stimulation, and negative pressure wound therapy.
“One of the most important advantages I can offer patients is access to a full spectrum of therapies based on scientific evidence,” Dr. Lavery says.
“We use the proven treatments that might be considered old school, as well as many of the most innovative treatments in the world. And because we collaborate with industry to study new technologies, we often have new treatments that are not available at other centers,” he adds.
He says seeing patients at UT Southwestern’s Wound Care Clinic offers another distinct advantage because there he has a close working relationship with world-class vascular surgeons and vascular testing. He notes that, for many people with diabetic foot wounds, optimizing the blood flow to the foot is the difference between healing or losing their leg.
Dr. Lavery says great progress has been accomplished with science-based strategies to save limbs.
However, he stresses patients should seek care sooner rather than later because early treatment can be key to improving their chances of recovery and preventing an amputation.
As director of research for UT Southwestern’s Department of Plastic Surgery, Dr. Lavery leads a team that’s focused on improving treatment and prevention of diabetic foot complications. Dr. Lavery’s groundbreaking work has received research funding from the National Institute of Health (NIH), Veterans Administration (VA), American Diabetes Association, Agency for Health Quality Research, Qatar National Research Foundation, American College of Foot and Ankle Surgeons, American Podiatric Medical Association, and private industry. This includes studies funded by the National Institutes of Health (NIH), such as identifying biomarkers in diabetic patients to diagnose and monitor foot infections and to help doctors understand why some people heal and some don’t.
Dr. Lavery brings a unique perspective to treating wounds and understands foot and ankle complications on a personal level. Dr. Lavery’s father was born with a clubfoot, and his great grandfather lost both legs to disease. So he uses that experience to relate to patients and help them understand the disease process and their treatment options.
- American Diabetes Association
- American Board of Podiatric Surgery
- American College of Foot and Ankle Surgeons
- Texas Podiatric Medical Association
- Royal College of Physicians and Surgeons (Glasgow)
- The Karel Bakker Diabetic Foot Award 2019, Given to honor scientists and clinicians who have major contributions to the understanding, prevention, and treatment of diabetic foot disease, 8th International Symposium on the Diabetic Foot Conference, Amsterdam
- 14th Annual Edward James Olmos Award 2018, For advocacy in amputation prevention, Houston, Texas
- Medstar Georgetown Distinguished Achievement Award in Diabetic Limb Salvage 2018, Diabetic Limb Salvage Conference
- Symposium on Advanced Wound Care (SAWC) 3rd Place Oral Abstract 2018, Open-Label Extension Phase of The Chronic Diabetic Foot Ulcer Multicenter, Controlled, Randomized Clinical Trial Confirms Benefits Of Viable Cryopreserved Placental Membrane For Wound Closure and Reduction of Adverse Events
- Texas Podiatry Medical Association 2nd Place Oral Abstract 2017, Outcomes and adverse events in diabetic soft tissue infections and osteomyelitis
- Southwestern Foot and Ankle Conference 1st Place Oral Abstract 2016, Serial bone biopsies in patients with diabetic foot osteomyelitis; a case series
- Southwestern Foot and Ankle Conference 1st Place Oral Abstract 2015, The Infected Diabetic Foot: 16S r RNA sequencing to characterize the ecology of diabetic foot osteomyelitis
- American College of Foot and Ankle Surgeons 3rd Place Oral Abstract 2015, The Role of type 2 Diabetes and Metformin® on fracture healing in an experimental rat
Diagnostic Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein in Osteomyelitis of the Foot in Persons Without Diabetes.
Ryan EC, Ahn J, Wukich DK, Kim PJ, La Fontaine J, Lavery LA The Journal of foot and ankle surgery : official publication of the American College of Foot and Ankle Surgeons 2019 Jan
- Diagnostic Utility of Erythrocyte Sedimentation Rate and C-Reactive Protein in Osteomyelitis of the Foot in Persons Without Diabetes.